Waiver of receivables from a consolidated subsidiary
株式会社トランスジェニック (a consolidated subsidiary wholly owned by the company) and the reporting company
Kobe Research Center (listed as the site subject to the closure decision)
In the fiscal year ended March 2026, the company recorded business restructuring losses associated with the closure of the Kobe Research Center, loss compensation payments related to the identified GLP misconduct, and impairment losses on certain equipment.
The reporting company will record ¥543 million in provisions for doubtful accounts as an extraordinary loss in its non-consolidated financial statements. The amount will be eliminated in the consolidated financial statements and will have no impact on consolidated results.
Fiscal year ending March 2026
Company response
Closure of the Kobe Research Center
To strengthen the financial foundation of 株式会社トランスジェニック and facilitate an early recovery in its business performance
| Item | Details |
|---|---|
| Event name | Waiver of receivables from a consolidated subsidiary |
| Date of occurrence | 13 May 2026 (date of the Board of Directors' resolution and execution of the receivables waiver) |
| Subject Entity | 株式会社トランスジェニック (a consolidated subsidiary wholly owned by the company) and the reporting company |
| Target Locations / Products | Kobe Research Center (listed as the site subject to the closure decision) |
| Cause | In the fiscal year ended March 2026, the company recorded business restructuring losses associated with the closure of the Kobe Research Center, loss compensation payments related to the identified GLP misconduct, and impairment losses on certain equipment. |
| Amount of Impact on Business Performance | The reporting company will record ¥543 million in provisions for doubtful accounts as an extraordinary loss in its non-consolidated financial statements. The amount will be eliminated in the consolidated financial statements and will have no impact on consolidated results. |
| Accounting period in which recognized | Fiscal year ending March 2026 |
| Suspended operations | Closure of the Kobe Research Center |
| Outlook | To strengthen the financial foundation of 株式会社トランスジェニック and facilitate an early recovery in its business performance |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the financial foundation of 株式会社トランスジェニック and facilitate an early recovery in its business performance. The company cited business restructuring losses associated with the closure of the Kobe Research Center, loss compensation payments related to the identified GLP misconduct, and impairment losses on certain equipment as the background.